普雷迪尼索隆会损害21-基酶缺乏症的青少年的脊椎骨评分变化
Pattara Wiromrat1, Yutapong Raruenrom2, Phanpaphorn Namphaisan1
1Division of Endocrinology, Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Clinical and experimental pediatrics
|November 13, 2024
概括
患有21-基酶缺乏症 (21OHD) 的青少年通常具有受损的骨微型架构. 普雷迪尼索隆疗法对骨发育产生负面影响,这表明皮可能是保护骨健康的更好的一线治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
- 儿科内分泌学 儿科内分泌学
背景情况:
- 对21-基酶缺乏症 (21OHD) 的终身葡萄糖皮质激素 (GC) 治疗会增加骨折的风险.
- 尽管正常的骨矿物质密度 (BMD),但GC治疗个体的骨折可能会发生,这表明微观结构的变化.
研究的目的:
- 为了评估 21OHD.OHD 的青少年的脊椎骨微架构及其变化.
- 评估不同类型的皮质糖类药物治疗对这一群体骨微型架构的影响.
主要方法:
- 38名患有21OHD的青少年在1.5年内进行了基线和随访的腰椎骨髓 BMD (LSBMD) 的评估.
- 使用iNsight软件分析了骨微架构的间接测量 - - 轨道骨评分 (TBS).
- 损伤的BMD和TBS被定义为z分数≤-1.5.5.
主要成果:
- 在基线时,18%的参与者TBS受损,5%的BMD受损.
- 服用普雷迪尼索隆的青少年与服用皮的青少年相比,TBS的年增幅较小 (P=0.028).
- 体重指数百分位和丸激素度预测了较高的基线TBSz分数,而普雷尼索隆使用预测了较低的年度TBS变化.
结论:
- 患有21OHD的青少年表现出受损骨微型架构的高患病率.
- 普雷尼索隆治疗与较差的骨微型架构发展有关.
- 在21岁OHD的青少年中,皮可能更适合保存骨微型架构.
更多相关视频
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
473
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
2.2K
相关概念视频
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Adrenal Gland Disorders
1.3K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.3K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
